Leica Biosystems Launches Expanded Line of Surgipath AffirmSeal Pre-Filled Specimen Jars for Easy Handling and Safe Transport of Various-Sized Tissue Specimens

RICHMOND, ILLINOIS, June 28, 2016 — Leica Biosystems announces the addition of four new sizes to the current 20mL Surgipath AffirmSeal Pre-Filled Specimen Jar. The new sizes include 40mL, 60mL, 90mL and 120mL, and are offered in multiple packaging configurations. Pre-filled with 10% neutral buffered formalin, AffirmSeal jars are specifically designed for safe collection and transport of various sized specimens.

“We are very excited to expand our portfolio by offering new sizes of the AffirmSeal pre-filled jars,” stated Leo Kulmaczewski, Vice President, Operations & Site Leader of Leica Biosystems Core Histology Consumables Business. “The extra wide diameter of the 90mL and 120mL jars provides ease of use when handling large tissue specimens. Additionally, the product design helps prevent leakage during transport.”

The jars feature a plastic mold design that creates two clearly audible and tactile “clicks” when the lid is properly secured. This provides confirmation that the specimen is secure, helps prevent leakage, and offers an added level of safety from formalin fumes for couriers and technicians.

AffirmSeal jars are made of durable plastic to prevent cracking when inadvertently dropped, and comply with 95 kPa pressure testing for safe air shipment and use in pneumatic transport systems. The packaging is made of chipboard material, making it safe for operating room use. In terms of configurations, Mini-Pak sizes allow for easy breakdown of the cases for distribution to other labs and physician offices. Alternatively, flat packs save storage space and provide added durability during transit.

The new AffirmSeal sizes will be available for pre-order starting today on LeicaBiosystems.com. Pre-orders will ship by 7/20.

About Leica Biosystems

Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 9 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Visit LeicaBiosystems.com for more information.

Source: Leica Biosystems